Published in Women's Health Weekly, November 9th, 2006
"The design of this phase 1 pharmacokinetic study was a single-center, open-label, 2-period, 9-group study. After administration of a single 200-mg dose of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly